LAXAI is a CRDMO that offers a range of services to support the development of small molecule drug candidates.
Our team provides guidance to clients to bring their program from the Investigational New Drug (IND) stage to commercialization. Our scientific skill set includes drug material and product development, as well as analytical solutions. With more than 15 years of experience, our skilled scientists works with customers to build a chemical in a cost-effective and timely manner throughout the clinical development process.
Our competencies include pre-formulation/formulation, material science, non-GMP and GMP intermediate manufacturing, clinical-stage API manufacturing, enzymatic reactions, batch mode and continuous flow chemical process R&D, and biotransformation. Our competent scientists are experts in route scouting and manufacturing process optimization and works closely with customers to ensure success.
At LAXAI, our experienced scientists understand the complexities and obstacles involved in drug development, both upstream and downstream. As a result, we offer robust analytical method development capabilities to help you determine the solid form(s) of your active drug in formulations, as well as assess the stability of your drug product and formulation. With our powerful analytical solutions, you can be confident in the quality, safety, and efficacy of your drug candidate as it progresses through development.